ADC Therapeutics SA (ADCT)
4.15
+0.11
(+2.72%)
USD |
NYSE |
May 15, 14:50
ADC Therapeutics Total Liabilities (Quarterly): 502.42M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 502.42M |
| December 31, 2023 | 503.03M |
| September 30, 2023 | 521.08M |
| June 30, 2023 | 515.89M |
| March 31, 2023 | 429.99M |
| December 31, 2022 | 411.41M |
| September 30, 2022 | 426.98M |
| June 30, 2022 | 405.12M |
| March 31, 2022 | 419.22M |
| December 31, 2021 | 451.88M |
| Date | Value |
|---|---|
| September 30, 2021 | 450.67M |
| June 30, 2021 | 220.47M |
| March 31, 2021 | 163.74M |
| December 31, 2020 | 178.19M |
| September 30, 2020 | 145.47M |
| June 30, 2020 | 177.54M |
| December 31, 2019 | 26.53M |
| June 30, 2019 | 22.85M |
| December 31, 2018 | 24.32M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
22.85M
Minimum
Jun 2019
521.08M
Maximum
Sep 2023
331.80M
Average
415.31M
Median
Total Liabilities (Quarterly) Benchmarks
| Roche Holding AG | 68.11B |
| Novartis AG | 54.58B |
| AC Immune SA | 25.05M |
| CRISPR Therapeutics AG | 355.08M |
| Addex Therapeutics Ltd | 4.163M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 307.97M |
| Shareholders Equity (Quarterly) | -194.45M |
| Debt to Equity Ratio | -0.5823 |
| Current Ratio | 4.608 |
| Net Debt Paydown Yield | -0.19% |